Evidence map›Paper›PMID 33693474›Full record

ArticleAmerican journal of hypertension2021

Medication Adherence: Expanding the Conceptual Framework.

Marie Krousel-Wood, Leslie S Craig, Erin Peacock, Emily Zlotnick, Samantha O'Connell, David Bradford, Lizheng Shi, Richard Petty

Abstract read
In one paragraph

Article in American journal of hypertension, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Translation and Validation of the Medication Understanding and Use Self-Efficacy Scale Among Patients With Type 2 Diabetes in Taiwan.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Pre-stroke Adherence to Hypertension Medications in a Bi-racial United States Stroke Belt.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marie Krousel-WoodDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.ORCID 0000-0001-9662-3947
Leslie S CraigDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Erin PeacockDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Emily ZlotnickDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Samantha O'ConnellOffice of Academic Affairs, Tulane University, New Orleans, Louisiana, USA.
David BradfordDepartment of Public Administration and Policy, University of Georgia, Athens, Georgia, USA.
Lizheng ShiDepartment of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
Richard PettyDepartment of Psychology, The Ohio State University, Columbus, Ohio, USA.

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Tulane COBRE in Cardiometabolic Diseases Clinical Research CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Katherine Teresa Mills · 2016 to 2026
$25.3M
Tulane Building Interdisciplinary Research Careers in Women's Health (BIRCWH)K12HD043451 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI KROUSEL-WOOD, MARIE · 2002 to 2023
$9.9M
Dissemination and Implementation of the SPRINT Study Findings in Underserved PopulationsR01HL133790 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI HE, JIANG, KROUSEL-WOOD, MARIE · 2017 to 2021
$6.3M
Model Based Approach to Improving Hypertension Control in PopulationsR01HL130500 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MORAN, ANDREW EDWARD · 2016 to 2019
$2.4M
Cohort Study of Medication Adherence Among Older AdultsR01AG022536 · NIA · OCHSNER CLINIC FOUNDATION · PI KROUSEL-WOOD, MARIE · 2005 to 2009
$2.4M
NCATS NIH HHS UL1 TR001417NHLBI NIH HHS R01 HL130500NHLBI NIH HHS R01 HL133790NIA NIH HHS R01 AG022536NICHD NIH HHS K12 HD043451NIGMS NIH HHS P20 GM109036NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Interventions targeting traditional barriers to antihypertensive medication adherence have been developed and evaluated, with evidence of modest improvements in adherence. Translation of these interventions into population-level improvements in adherence and clinical outcomes among older adults remains suboptimal. From the Cohort Study of Medication Adherence among Older adults (CoSMO), we evaluated traditional barriers to antihypertensive medication adherence among older adults with established hypertension (N = 1,544; mean age = 76.2 years, 59.5% women, 27.9% Black, 24.1% and 38.9% low adherence by proportion of days covered (i.e., PDC <0.80) and the 4-item Krousel-Wood Medication Adherence Scale (i.e., K-Wood-MAS-4 ≥1), respectively), finding that they explained 6.4% and 14.8% of variance in pharmacy refill and self-reported adherence, respectively. Persistent low adherence rates, coupled with low explanatory power of traditional barriers, suggest that other factors warrant attention. Prior research has investigated explicit attitudes toward medications as a driver of adherence; the roles of implicit attitudes and time preferences (e.g., immediate vs. delayed gratification) as mechanisms underlying adherence behavior are emerging. Similarly, while associations of individual-level social determinants of health (SDOH) and medication adherence are well reported, there is growing evidence about structural SDOH and specific pathways of effect. Building on published conceptual models and recent evidence, we propose an expanded conceptual framework that incorporates implicit attitudes, time preferences, and structural SDOH, as emerging determinants that may explain additional variation in objectively and subjectively measured adherence. This model provides guidance for design, implementation, and assessment of interventions targeting sustained improvement in implementation medication adherence and clinical outcomes among older women and men with hypertension.

Indexed as

Antihypertensive AgentsHypertensionMedication AdherenceAgedCohort StudiesFemaleHumansMaleSelf ReportAntihypertensive Agentsblood pressureconceptual modelhypertensionmedication adherenceolder women and men

Identifiers

PMID33693474
PMCPMC8457429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.